A Simulation Analysis of an Influenza Vaccine Production Plant in Areas of High Humanitarian Flow. A Case Study for the Region of Norte de Santander (Colombia)

The production of vaccines of biological origin presents a tremendous challenge for researchers. In this context, animal cell cultures are an excellent alternative for the isolation and production of biologicals against several viruses since they have an affinity with viruses and a great capacity for their replicability. Different variables have been studied to know the system's ideal parameters, allowing it to obtain profitable and competitive products. Consequently, this work focuses its efforts on evaluating an alternative for producing an anti-influenza biological from MDCK cells using SuperPro Designer v8.0 software. The process uses the DMEN culture medium supplemented with nutrients as raw material for cell development; the MDCK cells were obtained from a potential scale-up with a final working volume of 500 L, four days of residence time, inoculum volume of 10%, and continuous working mode with up to a total of 7400 h/Yr of work. The scheme has the necessary equipment for the vaccine's production, infection, and manufacture with yields of up to 416,698 units/h. In addition, it was estimated to be economically viable to produce recombinant vaccines with competitive prices of up to 0.31 USD/unit.

[1]  Y. Valero,et al.  BEI Inactivated Vaccine Induces Innate and Adaptive Responses and Elicits Partial Protection upon Reassortant Betanodavirus Infection in Senegalese Sole , 2021, Vaccines.

[2]  J. Wood,et al.  Global production capacity of seasonal and pandemic influenza vaccines in 2019 , 2020, Vaccine.

[3]  Licelly Canizales,et al.  SuperPro Designer®, User-Oriented Software Used for Analyzing the Techno-Economic Feasibility of Electrical Energy Generation from Sugarcane Vinasse in Colombia , 2020, Processes.

[4]  Siti Rozaimah Sheikh Abdullah,et al.  Comparative Study between Avian Cell and Mammalian Cell in Production of Influenza Vaccine Shariah Compliance , 2020, IOP Conference Series: Materials Science and Engineering.

[5]  C. Prieto,et al.  A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications. , 2019, Comparative immunology, microbiology and infectious diseases.

[6]  Manish M Patel,et al.  Polio endgame: Lessons for the global rotavirus vaccination program. , 2019, Vaccine.

[7]  J. Eiros,et al.  Cell culture-derived flu vaccine: Present and future , 2018, Human vaccines & immunotherapeutics.

[8]  Nico Vandaele,et al.  A review of integrated supply chain network design models: Key issues for vaccine supply chains , 2016 .

[9]  Udo Reichl,et al.  Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production , 2016, Applied Microbiology and Biotechnology.

[10]  Shawn T. Brown,et al.  Landscaping the structures of GAVI country vaccine supply chains and testing the effects of radical redesign. , 2015, Vaccine.

[11]  P. Alves,et al.  Improved virus purification processes for vaccines and gene therapy , 2015, Biotechnology and bioengineering.

[12]  Y. Genzel.  Designing cell lines for viral vaccine production: Where do we stand? , 2015, Biotechnology journal.

[13]  C. Reed,et al.  Estimating Influenza Disease Burden from Population-Based Surveillance Data in the United States , 2015, PloS one.

[14]  P. Moyle.  Progress in Vaccine Development , 2015, Current protocols in microbiology.

[15]  Alexandros Koulouris,et al.  Biopharmaceutical Process Optimization with Simulation and Scheduling Tools. , 2014, Bioengineering.

[16]  Shawn T. Brown,et al.  A planning model for the WHO-EPI vaccine distribution network in developing countries , 2014 .

[17]  Miladys Limonta,et al.  Simulation for the recovery of plasmid for a DNA vaccine , 2013 .

[18]  Shawn T. Brown,et al.  Augmenting Transport versus Increasing Cold Storage to Improve Vaccine Supply Chains , 2013, PloS one.

[19]  Suzanne S Farid,et al.  Process economics of industrial monoclonal antibody manufacture. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  Sivakumar Kumaresan,et al.  Modelling and Optimization of Eurycoma longifolia Water Extract Production , 2006 .

[21]  S. Chang,et al.  Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Yao-ming Huang,et al.  Perfusion seed cultures improve biopharmaceutical fed‐batch production capacity and product quality , 2014, Biotechnology progress.